Navigation Links
Investigation of American Oriental Bioengineering, Inc. by Securities Lawyers at Goldfarb LLP Law Firm for Potential Shareholder Claim
Date:6/26/2012

DALLAS, June 26, 2012 /PRNewswire/ -- Goldfarb LLP is investigating whether the board of directors of American Oriental Bioengineering, Inc. (OTC: AOBI) violated shareholder protection laws as evidenced through alleged inconsistencies in the company's financial statements. Concerned AOBI investors who purchased stock before June 15, 2012 are encouraged to contact attorney Hamilton Lindley at 877-583-2855 or hlindley@goldfarbllp.com about their rights and remedies.

"On March 16, 2012, auditor Ernst & Young informed the company's audit committee of discrepancies in the company's financial statements for fiscal year 2011. As a result, trading halted, the stock was delisted, and shares fell almost 60%," securities lawyer Hamilton Lindley said. "Our proposed shareholder lawsuit will seek to ensure that proper controls are placed to ensure accurate financial reporting, to correct any improper behavior, and to improve the company's value for investors."

Goldfarb LLP lawyers have significant experience representing shareholders and whistleblowers in securities lawsuits nationwide. American Oriental Bioengineering, Inc. shareholders – or anyone with knowledge about this situation – should contact lawyer Hamilton Lindley at hlindley@goldfarbllp.com or 877-583-2855.

Hamilton Lindley
Goldfarb LLP
2501 N. Harwood, Ste. 1801
Dallas, TX 75201
(877) 583-2855 Toll Free Telephone
(214) 583-2233 Local Phone Number
(214) 583-2234 Fax Number
hlindley@goldfarbllp.com 
www.goldfarbllp.com


'/>"/>
SOURCE Goldfarb LLP
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology news :

1. Child welfare investigation predicts mental health problems in young children
2. American College of Rheumatology releases first classification criteria for polymyalagia rheumatica
3. Common North American frog identified as carrier of deadly amphibian disease
4. UC research tests new tool to guide reintroduction of the American chestnut
5. American Society of Plant Biologists honors early career women scientists
6. Scripps Research Institute Professor Gerald F. Joyce elected to American Academy of Arts & Sciences
7. Professor known for work with hunter-gatherers elected to American Academy of Arts and Sciences
8. Elsevier selected as new publisher of the American Journal of Geriatric Psychiatry
9. New study published on fertility awareness among American university students
10. The American Society for Microbiology honors Ellen Jo Baron
11. Steve Fisher joins American Health IT LLC as VP of Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2017)... AWRE ), a leading supplier of biometrics software ... year ended December 31, 2016. Revenue for ... $6.9 million in the same quarter last year. Operating income ... to $2.6 million in the fourth quarter of 2015. Net ... or $0.02 per diluted share, which compares to $1.8 million, ...
(Date:2/8/2017)... Report Highlights The global biosurgery market should ... 2016 at a compound annual growth rate (CAGR) of ... An overview of the global market for biosurgery. - ... and 2016, and projections of compound annual growth rates ... the basis of product type, source, application, and region. ...
(Date:2/7/2017)... , February 7, 2017 ... Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or the "Company") ... electronic transaction processing services, is pleased to announce the ... Company. Effective January 31, 2017, Philip ... of Directors, CEO and President.  An experienced payment industry ...
Breaking Biology News(10 mins):
(Date:2/27/2017)... February 27, 2017 A Europe-wide survey of ... researchers using animals in their research treat them with due care. ... and detailed analysis of the results indicates that there is a ... to put into practice the principles of the 3Rs (Refine, ... What ...
(Date:2/27/2017)... Feb. 27, 2017 AcelRx Pharmaceuticals, Inc. ... the development and commercialization of innovative therapies for ... the U.S. Food and Drug Administration (FDA) has ... section 505(b)(2) for DSUVIA™ (formerly ARX-04) (sufentanil sublingual ... with moderate-to-severe acute pain in a medically supervised ...
(Date:2/27/2017)... and HAMILTON, Bermuda ... (NASDAQ: ADXS ) and ... companies focused on developing cancer immunotherapies, today announced ... develop a novel cancer immunotherapy agent using Advaxis, ... SELLAS, patented WT1 targeted heteroclitic peptide antigen mixture ...
(Date:2/27/2017)... ... February 27, 2017 , ... In starting a program to hire ... grandfather, “Hire for attitude. Train for skill.” , In keeping with this philosophy, the ... as a salesman. Zamzow is hoping to replicate the practice throughout the company. , ...
Breaking Biology Technology: